Natural diabetogenic factor
Kudriashov, B.A.
Sovetskaia Meditsina 7: 51-54
1989
ISSN/ISBN: 0038-5077 PMID: 2678523 Document Number: 344485
Document emailed within 1 workday
Related Documents
Kudriashov, B.A.; Ammosova, I.M.; Liapina, L.A.; Ul'ianov, A.M. 1987: Physicochemical properties of the diabetogenic factor and its complex with heparin Farmakologiia i Toksikologiia 50(3): 49-52Kudriashov, B.A.; Liapina, L.A.; Azieva, L.D. 1989: Isolation and various physico-chemical properties of diabetogenic factor from the blood of patients with diabetes Voprosy Meditsinskoi Khimii 35(6): 63-66
Baskakova, G.M.; Kudriashov, B.A.; Pytel', I.A. 1981: Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes Problemy Endokrinologii 27(4): 42-45
Kudriashov, B.A.; Zhukovskiĭ, M.A.; Shcherbacheva, L.N.; Ul'ianov, A.M.; Bazaz'ian, G.G. 1985: Changes in the diabetogenic factor activity in the blood plasma of children with diabetes mellitus resulting from systematic heparin administration Pediatriia 1985(8): 46-47
Ranivontsoarivony, M.; Noronavalona, A.; Raharison, N.; Rajaona, H.R. 2001: Is manioc a diabetogenic factor? Apropos of a case of diabetes mellitus with a large consumption of crude manioc Bulletin de la Societe de Pathologie Exotique 94(4): 312-314
Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M. 1991: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells Journal of Immunology 146(9): 3074-3081
Stephens, T.J.; Herndon, J.H.; Colón, L.E.; Gottschalk, R.W. 2011: The impact of natural sunlight exposure on the UVB-sun protection factor (UVB-SPF) and UVA protection factor (UVA-PF) of a UVA/UVB SPF 50 sunscreen Journal of Drugs in Dermatology: Jdd 10(2): 150-155
Miller, V.E.; Pohajdak, B.; Greenberg, A.H. 1983: Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance Journal of the National Cancer Institute 71(2): 377-384
Bialas, T.; Kolitz, J.; Levi, E.; Polivka, A.; Oez, S.; Miller, G.; Welte, K. 1988: Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin Cancer Research 48(4): 891-898
Schottenfeld, D. 1983: Radiation as a risk factor in the natural history of colorectal cancer Gastroenterology 84(1): 186-187
Dziuba, A.N.; Frolov, V.M.; Peresadin, N.A. 1993: The significance of a natural inhibitory factor in the pathogenesis of disseminated sclerosis Likars'ka Sprava 1993(2-3): 93-95
Abdullaev, N.K.; Guliamov, B.D. 1975: Diabetogenic and atherogenic effects of glucose Voprosy Pitaniia 2: 32-36
White, J.A.; Bolstridge, M.C.; Downing, H.J.; Helm, E.H.; Klomfass, H.J. 1974: Diabetogenic drugs in the vervet monkey South African Medical Journal 48(7): 273-276
Devaraj, H.; Shanmugasundaram, K.R.; Shanmugasundaram, E.R. 1986: Role of patulin as a diabetogenic lactone Indian Journal of Experimental Biology 24(7): 458-459
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Kieu Hak Don 1979: Humoral factor study of natural immunity in Sonne and Flexner dysenteries Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 110-111
Gnuchev, N.V.; Sashchenko, L.P.; Luk'ianova, T.I.; Rebizova, T.V.; Kirillova, M.A. 1987: Detection of a perforin-like protein from the soluble cytotoxic factor of natural killer cells Molekuliarnaia Biologiia 21(4): 1117-1123
Assan, R.; Larger, E. 1996: Chronic diabetogenic pancreatitis: current aspects and new prospects Journees Annuelles de Diabetologie de l'Hotel-Dieu 1996: 85-97
Rusescu, A.; Pop, M. 1971: Prevention of diabetogenic disturbances in children with toxic states Pediatria 20(3): 225-230
Espevik, T.; Figari, I.S.; Ranges, G.E.; Palladino, M.A. 1988: Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1 Journal of Immunology 140(7): 2312-2316